Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martinez–Saguer I et al. – pC1–INH concentrate has a long median terminal elimination half–life and rapidly reaches maximum plasma concentrations. This rapid onset of clinical efficacy is essential in patients suffering from HAE.

Related Articles

Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09    Relevance Score: 68%

Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 66%

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 66%

Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks
Allergy and Asthma Proceedings, 10/14/09    Relevance Score: 64%

Update on therapeutic developments for hereditary angioedema
Allergy and Asthma Proceedings, 10/12/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address